Table. Characteristics, Procedural Results and Clinical Outcomes of 18 Patients.
| No. | Sex/Age | IV tPA | FAT, minutes | Occlusion site | Initial NIHSS | Risk factors | Total number of pass (Pre-/Post-tirofiban) | Tirofiban dose | TICI | 7-day NIHSS | 3-month mRS | Complication |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | F/66 | Yes | 156 | Rt. M2 | 14 | HTN, cancer | 3 (2/1) | 0.75 mg | 3 | 0 | 0 | - |
| 2 | M/50 | No | 34 | Lt. M1 | 20 | HCMP, newly Afib, old ICH | 3 (2/1) | 0.5 mg | 3 | 5 | 2 | Distal embolism |
| 3 | M/71 | No | 70 | Rt. T-ICA | 18 | HTN, Smoker | 2 (1/1) | 0.2mg | 3 | 14 | 3 | Petechial hemorrhage |
| 4 | M/65 | Yes | 43 | Lt. M2 | 13 | Afib, Smoker, CAOD | 2 (1/1) | 0.25 mg | 2b | 0 | 0 | - |
| 5 | M/54 | No | 20 | Lt. M2 | 6 | Afib, HTN, Smoker | 3 (2/1) | 0.25 mg | 2b | 2 | 0 | - |
| 6 | F/66 | Yes | 123 | BA | 8 | HTN, DM, Afib | 3 (2/1) | 0.2 mg | 3 | 21 | 6 | - |
| 7 | F/82 | No | 113 | Rt. M1 | 15 | Afib, CAOD, old CVA | 4 (3/1) | 0.4 mg | 0* | 15 | 4 | Petechial hemorrhage |
| 8 | M/54 | No | 87 | BA | 14 | HTN, Smoker | 3 (2/1) | 0.2 mg | 1* | 2 | 1 | - |
| 9 | F/87 | No | 61 | M1 | 14 | DM, HTN, old CVA | 3 (1/2) | 0.4 mg × 2 | 2b | 7 | 4 | Distal embolism |
| 10 | M/77 | No | 70 | Lt. M1 | 18 | Afib, DVT, ASO, Smoker, ICH | 4 (3/1) | 0.3 mg | 2b | 14 | 5 | Petechial hemorrhage |
| 11 | M/80 | No | 85 | Lt. M1 | 19 | HF, CAOD, old CVA | 3 (2/1) | 0.3 mg | 3 | Expired | 6 | ICH, distal emboli, Wire perforation |
| 12 | M/55 | No | 210 | Rt. M1 | 15 | - | 4 (3/1) | 0.2 mg | 0* | 8 | 2 | Asymtomatic ICH |
| 13 | M/64 | No | 40 | Lt. M1 | 13 | Cancer, DM | 2 (1/1) | 0.3 mg | 2b | 10 | 5 | - |
| 14 | M/61 | No | 30 | Lt. M1 | 15 | - | 4 (3/1) | 0.3 mg | 2b | 6 | 1 | Distal embolism |
| 15 | F/87 | Yes | 94 | Lt. T-ICA | 20 | Afib | 3 (2/1) | 0.3 mg | 2b | 3 | 6 | Petechial hemorrhage |
| 16 | M/39 | No | 490 | Lt. M1 | 17 | HTN | 2 (1/1) | 0.25 mg | 2b | 6 | 2 | Distal embolism |
| 17 | M/53 | No | 480 | Lt. M1 | 10 | AVR, Smoker | 3 (2/1) | 0.55 mg | 2a | 6 | 2 | - |
| 18 | M/92 | No | 250 | Rt. M1 | 29 | HTN, Smoker | 2 (1/1) | 0.3 mg | 2b | 29 | 5 | - |
Abbreviations: IV tPA, intravenous recombinant tissue plasminogen activator; FAT, first found abnormal time; NIHSS, the National Institute of Health Scale Score; mRS, modified Rankin score; M1 and M2, middle cerebral artery segment; T-ICA, distal ICA to ACA and MCA; BA, Basilar artery; HTN, hypertension; DM, Diabetes mellitus; Afib, atrial fibrillation; CAOD, coronary artery occlusive disease; ICH, intracranial hemorrhage; CVA, cerebrovascular accident; DVT, deep vein thrombosis; ASO, arteriosclerotic obliterans; AVR, aortic valve regurgitation
*: additional angioplasty with stent insertion was performed to achieve successful recanalization.